Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Familial dilated cardiomyopathy]

M Csanády1

  • 1Szent-Györgyi Albert Orvostudományi Egyetem, Szeged, II. sz. Belgyógyászati Klinika.

Orvosi Hetilap
|March 7, 1993
PubMed
Summary
This summary is machine-generated.

Familial dilatative cardiomyopathy presents earlier and progresses faster than the nonfamilial form, with a significantly lower five-year survival rate. This genetic heart condition impacts younger individuals and has a poorer prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrophysiological measurements with electrode types of different perimodiolar properties and the same cochlear implant electronics - a retrospective comparison study.

Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale·2019
Same author

Does increased aortic stiffness predict reduced coronary flow velocity reserve in patients with suspected coronary artery disease?

Acta physiologica Hungarica·2012
Same author

Na(+)/Ca(2+) exchanger inhibition exerts a positive inotropic effect in the rat heart, but fails to influence the contractility of the rabbit heart.

British journal of pharmacology·2008
Same author

Relevance of anaesthesia for dofetilide-induced torsades de pointes in alpha1-adrenoceptor-stimulated rabbits.

British journal of pharmacology·2007
Same author

Images in cardiology. Twiddler's syndrome in a patient with an implantable-cardioverter defibrillator.

Heart (British Cardiac Society)·2006
Same author

Coronary flow reserve, insulin resistance and blood pressure response to standing in patients with normoglycaemia: is there a relationship?

Diabetic medicine : a journal of the British Diabetic Association·2005
Same journal

[Hungarian primary care: facts, problems and expectations].

Orvosi hetilap·2026
Same journal

[The role of obesity and weight reduction in obstructive sleep apnea].

Orvosi hetilap·2026
Same journal

[Mucinous cystic neoplasm of the liver].

Orvosi hetilap·2026
Same journal

[Towards the elimination of iodine deficiency in Hungary].

Orvosi hetilap·2026
Same journal

[Predictive factors of vocal cord paralysis following thyroid surgery].

Orvosi hetilap·2026
Same journal

[Letter to the editor].

Orvosi hetilap·2026
See all related articles

Area of Science:

  • Cardiology
  • Genetics
  • Internal Medicine

Context:

  • Dilatative cardiomyopathy (DCM) is a significant cause of heart failure.
  • Understanding familial DCM is crucial for early diagnosis and management.
  • This study reviews existing literature and presents new data on familial DCM.

Purpose:

  • To provide a state-of-the-art overview of familial dilatative cardiomyopathy.
  • To analyze the incidence, inheritance patterns, clinical presentation, and prognosis of familial DCM.
  • To compare familial DCM with the nonfamilial form.

Summary:

  • Familial DCM accounts for a notable incidence (21.5%) in DCM patients, predominantly with autosomal dominant inheritance.
  • Familial DCM exhibits an earlier onset of cardiomegaly and symptoms compared to nonfamilial DCM.

Related Experiment Videos

  • The five-year survival rate is significantly lower in familial DCM (23.1%) versus nonfamilial DCM (52.1%).

    • Impact:

    • Highlights the aggressive nature and poorer prognosis of familial dilatative cardiomyopathy.
    • Emphasizes the need for genetic screening in families with DCM.
    • Informs clinical practice regarding earlier symptom onset and accelerated disease progression in genetic DCM.